Clinical Consultations™: Expert Opinions on the Management of Ocular Health in Glaucoma – Updating the Armamentarium with Advances in Treatment

Release Date: March 18, 2021
Expiration Date: March 18, 2022

Activity Overview

This Clinical Consultations™ is a video-based program in which two experts use a case-based approach to discuss the treatment and management of glaucoma. In this activity, faculty focus on current topical agents and new and emerging sustained-release therapies for the management of glaucoma. This engaging format is designed to help clinicians identify best practices to slow disease progression while minimizing adverse effects of long-term treatment to improve outcomes for their patients with this silent, sight-threatening disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Allergan.

Target Audience

This activity is intended for ophthalmologists and other health care professionals who may encounter patients with glaucoma in clinical practice.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe current intraocular agents according to efficacy, safety, and preservative content
• Identify common safety concerns of long-term use of benzalkonium chloride-containing medications on the conjunctiva, cornea, lens, and trabecular meshwork
• Assess the efficacy and safety of alternative preservatives, preservative-free solutions and available sustained-release formulations for the treatment of intraocular pressure

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible entities.

Faculty

Sandra M. Johnson, MD
Glaucoma and Cataract Service
Mason Eye Clinic
Professor of Clinical Ophthalmology
University of Missouri School of Medicine
Columbia, MO

Disclosures: Dr. Sandra M. Johnson has no relevant financial relationships with ineligible companies.

Oluwatosin U. Smith, MD
Attending Physician
Glaucoma Associates of Texas
Dallas, TX

Disclosures: Grant/Research Support: Allergan; Consultant: Aerie Pharmaceuticals, Allergan, Bausch & Lomb, Glaukos Corporation, New World Medical; Speaker’s Bureau: Allergan, Aerie Pharmaceuticals, Bausch & Lomb.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.